MicroRNA-1298 is regulated by DNA methylation and affects vascular smooth muscle cell function by targeting connexin 43

Cardiovascular Research

Volumn 107, Issue 4, 2015, Pages 534-545

  Hu, Wei ^a   Wang, Mian ^a   Yin, Henghui ^a   Yao, Chen ^a   He, Qiong ^a   Yin, Leping ^b   Zhang, Chunxiang ^c   Li, Wen ^a   Chang, Guangqi ^a   Wang, Shenming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arteriosclerosis obliterans; Connexin 43; Methylation; microRNA; Smooth muscle cell

Indexed keywords

CONNEXIN 43; MICRORNA; MICRORNA 1298; UNCLASSIFIED DRUG; GJA1 PROTEIN, HUMAN; MIRN1298 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY INJURY; CAROTID BALLOON INJURY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LENTIVIRINAE; LUCIFERASE ASSAY; NEOINTIMA; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN TARGETING; PYROSEQUENCING; QUANTITATIVE STUDY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; VASCULAR SMOOTH MUSCLE CELL; CELL CULTURE; CELL LINE; CELL MOTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CONNEXIN 43; DNA METHYLATION; DOWN-REGULATION; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA;

EID: 84948151463     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv160     Document Type: Article

References (37)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
2. Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, Gamst A, Bundens WP, Fronek A. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation 2005;112:2703-2707.
3. Setacci C, Castelli P, Chiesa R, Grego F, Simoni GA, Stella A, Galzerano G, Sirignano P, De Donato G, Setacci F. Restenosis: a challenge for vascular surgeon. J Cardiovasc Surg (Torino) 2012;53:735-746.
4. Kim J, Zhang L, Peppel K, Wu JH, Zidar DA, Brian L, DeWire SM, Exum ST, Lefkowitz RJ, Freedman NJ. Beta-Arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ Res 2008;103:70-79.
5. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009;73:615-621.
6. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001;104:503-516.
7. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005;122:553-563.
8. Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y, Sun J. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013;113:1117-1127.
9. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588.
10. Wang M, LiW, ChangGQ, Ye CS, Ou JS, Li XX, Liu Y, Cheang TY, Huang XL, Wang SM. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 2011;31:2044-2053.
11. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu H, Lim J, Shyr C, Tan G, Zhou M, Lenhard B, Sandelin A, WassermanWW. JASPAR 2014: an extensively expanded and updated open-Access database of transcription factor binding profiles. Nucleic Acids Res 2014;42:D142-D147.
12. Johnstone SR, Kroncke BM, Straub AC, Best AK, Dunn CA, Mitchell LA, Peskova Y, Nakamoto RK, Koval M, LoCW, Lampe PD, Columbus L, Isakson BE. MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ Res 2012;111:201-211.
13. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007;39:86-93.
14. Ning Y, Huang H, Dong Y, Sun Q, Zhang W, Xu W, Li Q. 5-Aza-2-deoxycytidine inhibited PDGF-induced rat airway smooth muscle cell phenotypic switching. Arch Toxicol 2013;87:871-881.
15. Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, Brisset AC, Bochaton-Piallat ML, Kwak BR. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 2008;102:653-660.
16. Song M, Yu X, Cui X, Zhu G, Zhao G, Chen J, Huang L. Blockade of connexin 43 hemichannels reduces neointima formation after vascular injury by inhibiting proliferation and phenotypic modulation of smooth muscle cells. Exp Biol Med (Maywood) 2009; 234:1192-1200.
17. Joshi CN, Martin DN, Shaver P, Madamanchi C, Muller-Borer BJ, Tulis DA. Control of vascular smooth muscle cell growth by connexin 43. Front Physiol 2012;3:220.
18. Wentlandt K, Samoilova M, Carlen PL, El BH. General anesthetics inhibit gap junction communication in cultured organotypic hippocampal slices. Anesth Analg 2006;102: 1692-1698.
19. Stout C, Goodenough DA, Paul DL. Connexins: functions without junctions. Curr Opin Cell Biol 2004;16:507-512.
20. Hebert C, Stains JP. An intact connexin 43 is required to enhance signaling and gene expression in osteoblast-like cells. J Cell Biochem 2013;114:2542-2550.
21. Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo M, Dong L, Yin H, Gong B, Li Z, Wang F, SongW, Liu C, Ma Y, Zhang J, Zhao H, Li J, Yu J. MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. Plos One 2014;9:e88057.
22. Xing TJ, Xu HT, Yu WQ, Jiang DF. Methylation regulation of liver-specific microRNA-122 expression and its effects on the proliferation and apoptosis of hepatocellular carcinoma cells. Genet Mol Res 2013;12:3588-3597.
23. Borghini A, Cervelli T, Galli A, Andreassi MG. DNA modifications in atherosclerosis: from the past to the future. Atherosclerosis 2013;230:202-209.
24. Pfenniger A, Chanson M, Kwak BR. Connexins in atherosclerosis. Biochim Biophys Acta 2013;1828:157-166.
25. Kwak BR, Veillard N, Pelli G, Mulhaupt F, JamesRW, Chanson M, Mach F. Reduced connexin 43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003;107:1033-1039.
26. Chadjichristos CE, Matter CM, Roth I, Sutter E, Pelli G, Luscher TF, Chanson M, Kwak BR. Reduced connexin 43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 2006;113:2835-2843.
27. Jia G, Cheng G, Gangahar DM, Agrawal DK. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol 2008;44:882-890.
28. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84: 381-388.
29. Song D, Liu X, Liu R, Yang L, Zuo J, Liu W. Connexin 43 hemichannel regulates H9c2 cell proliferation by modulating intracellular ATP and [Ca2+]. Acta Biochim Biophys Sin (Shanghai) 2010;42:472-482.
30. House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 2008; 456:769-785.
31. Herve JC, Derangeon M, Sarrouilhe D, Giepmans BN, Bourmeyster N. Gap junctional channels are parts of multiprotein complexes. Biochim Biophys Acta 2012;1818: 1844-1865.
32. Matsushita T, Rama A, Charolidi N, Dupont E, Severs NJ. Relationship of connexin43 expression to phenotypic modulation in cultured human aortic smooth muscle cells. Eur J Cell Biol 2007;86:617-628.
33. Giepmans BN. Role of connexin43-interacting proteins at gap junctions. Adv Cardiol 2006;42:41-56.
34. Shen YJ, Zhu XX, Yang X, Jin B, Lu JJ, Ding B, Ding ZS, Chen SH. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation. J Nat Med 2014;68: 623-629.
35. Kavurma MM, Khachigian LM. ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. J Cell Biochem 2003;89:289-300.
36. Cao JJ, Kurimoto P, Boudignon B, Rosen C, Lima F, Halloran BP. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. J Bone Miner Res 2007;22: 1271-1279.
37. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol 1997;17:3174-3184.